Literature DB >> 27187762

Estimates of premorbid ability in a neurodegenerative disease clinic population: comparing the Test of Premorbid Functioning and the Wide Range Achievement Test, 4th Edition.

Jody-Lynn Berg1, January Durant1, Sarah J Banks1, Justin B Miller1.   

Abstract

OBJECTIVE: Two frequently used measures to assess premorbid intellectual ability include the Wide Range Achievement Test, 4th Edition Reading Subtest (WRAT-4 READ) and the Test of Premorbid Functioning (TOPF). The present study compared estimates obtained from these measures in a neurodegenerative disease population.
METHOD: Records from 85 referrals seen for neuropsychological evaluation in a neurodegenerative disorders clinic were reviewed. Evaluations included TOPF, WRAT-4 READ, and measures of memory, reasoning, language, and executive functioning. Pairwise correlations and concordance correlation coefficients (CCC) were calculated between raw scores and predicted intelligence estimates. Discrepancy scores were calculated between estimates and data were divided into three groups based on size of standardized discrepancy score: Equal, WRAT-4 READ > TOPF, and TOPF > WRAT-4 READ. analysis of variances compared groups on demographic characteristics and cognitive performance.
RESULTS: Despite strong Pearson correlation, CCC between predicted IQ estimates showed poor agreement between measures, with evidence of both fixed and proportional bias. Discrepancies ranged from -24.0 to 22.0 (M = 1.78, SD = 6.65), with TOPF generating higher estimates on average. Individuals performing better on WRAT-4 READ were significantly older (M age = 76.26, SD = 7.53) than those performing similarly on both measures and those performing better on TOPF (F (2, 82) = 7.31, p < .001). All other comparisons between groups on demographic variables and cognitive measures were non-significant.
CONCLUSIONS: Estimates of premorbid intelligence obtained from the TOPF and WRAT-4 READ have a strong linear relationship, but systematically generate inconsistent estimates in a neurodegenerative disease clinical sample and should not be used interchangeably.

Entities:  

Keywords:  Premorbid ability; Test of Premorbid Functioning; Wide Range Achievement Test; neurodegenerative disease

Mesh:

Year:  2016        PMID: 27187762     DOI: 10.1080/13854046.2016.1186224

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  4 in total

1.  Comparing the test of practical judgment with the neuropsychological assessment battery judgment subtest in a neurodegenerative disease clinic population.

Authors:  January Durant; Jody-Lynn Berg; Sarah Jane Banks; Justin Benjamin Miller
Journal:  Appl Neuropsychol Adult       Date:  2017-06-12       Impact factor: 2.248

2.  Psychometric Properties of the NIH Toolbox Cognition Battery in Healthy Older Adults: Reliability, Validity, and Agreement with Standard Neuropsychological Tests.

Authors:  Emmi P Scott; Anne Sorrell; Andreana Benitez
Journal:  J Int Neuropsychol Soc       Date:  2019-07-01       Impact factor: 2.892

3.  Gamma-induction in frontotemporal dementia (GIFTeD) randomized placebo-controlled trial: Rationale, noninvasive brain stimulation protocol, and study design.

Authors:  Martina Assogna; Giulia Sprugnoli; Daniel Press; Brad Dickerson; Joanna Macone; Sonia Bonnì; Ilaria Borghi; Ann Connor; Megan Hoffman; Nainika Grover; Bonnie Wong; Changyu Shen; Alessandro Martorana; Molly O'Reilly; Giulio Ruffini; Georges El Fakhri; Giacomo Koch; Emiliano Santarnecchi
Journal:  Alzheimers Dement (N Y)       Date:  2022-02-03

4.  Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global Consortium.

Authors:  Gabriel A de Erausquin; Heather Snyder; Traolach S Brugha; Sudha Seshadri; Maria Carrillo; Rajesh Sagar; Yueqin Huang; Charles Newton; Carmela Tartaglia; Charlotte Teunissen; Krister Håkanson; Rufus Akinyemi; Kameshwar Prasad; Giovanni D'Avossa; Gabriela Gonzalez-Aleman; Akram Hosseini; George D Vavougios; Perminder Sachdev; John Bankart; Niels Peter Ole Mors; Richard Lipton; Mindy Katz; Peter T Fox; Mohammad Zia Katshu; M Sriram Iyengar; Galit Weinstein; Hamid R Sohrabi; Rachel Jenkins; Dan J Stein; Jacques Hugon; Venetsanos Mavreas; John Blangero; Carlos Cruchaga; Murali Krishna; Ovais Wadoo; Rodrigo Becerra; Igor Zwir; William T Longstreth; Golo Kroenenberg; Paul Edison; Elizabeta Mukaetova-Ladinska; Ekkehart Staufenberg; Mariana Figueredo-Aguiar; Agustín Yécora; Fabiana Vaca; Hernan P Zamponi; Vincenzina Lo Re; Abdul Majid; Jonas Sundarakumar; Hector M Gonzalez; Mirjam I Geerlings; Ingmar Skoog; Alberto Salmoiraghi; Filippo Martinelli Boneschi; Vibuthi N Patel; Juan M Santos; Guillermo Rivera Arroyo; Antonio Caballero Moreno; Pascal Felix; Carla Gallo; Hidenori Arai; Masahito Yamada; Takeshi Iwatsubo; Malveeka Sharma; Nandini Chakraborty; Catterina Ferreccio; Dickens Akena; Carol Brayne; Gladys Maestre; Sarah Williams Blangero; Luis I Brusco; Prabha Siddarth; Timothy M Hughes; Alfredo Ramírez Zuñiga; Joseph Kambeitz; Agustin Ruiz Laza; Norrina Allen; Stella Panos; David Merrill; Agustín Ibáñez; Debby Tsuang; Nino Valishvili; Srishti Shrestha; Sophia Wang; Vasantha Padma; Kaarin J Anstey; Vijayalakshmi Ravindrdanath; Kaj Blennow; Paul Mullins; Emilia Łojek; Anand Pria; Thomas H Mosley; Penny Gowland; Timothy D Girard; Richard Bowtell; Farhaan S Vahidy
Journal:  Alzheimers Dement (N Y)       Date:  2022-09-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.